| Current study | ECMO Group UK study[17] | REVA[28] | Non-ECMO ARDS Canada[20] |
---|---|---|---|---|
Follow-up, months | 8 | 6 | 12 | 6 |
Number | 21 | 90 | 12 | 117 |
Age, years | 36 ± 12 | 40 ± 13 | 36 (30, 39) | 45 (36, 58) |
APACHE II | 20 ± 6 | 20 ± 6 | n/a | 23 (17, 27) |
Pneumonia (%) | 100 | 62 | 100 | 53 |
ICU LOS, days | 21 (15, 29) | 24 (13, 41) | 38 (19, 67) | 25 (15, 45) |
Hospital LOS, median days | 28 (15, 29) | 35 (16, 74) | Â | 48 (27, 77) |
ECMO, % | 100 | 76 | 100 | n/a |
Death at 6 months, n/study population (%) | 3/21 (14) | 33/90 (37) | 24/67 (36) | 78/196 (40) |
Lowest PaO2/FiO2 ratio (day 1) | 80 ± 40 | 76 ± 30 | < 50* | < 200* |
PEEP | 15 ± 4.7 | 13.7 ± 9.6 | ≥ 5* | n/a |